GoodRx Holdings, Inc. (GDRX)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 551 | 745 | 767 | 750 | 792 | 797 | 785 | 800 |
| Operating profit | $m | 87 | 80 | ||||||
| Net profit | $m | -294 | -25 | -33 | -9 | 16 | 30 | 16 | 112 |
| EPS reported | $ | 0.09 | 0.04 | ||||||
| Operating cashflow per share | $ | 0.47 | 0.59 | ||||||
| Capex per share | $ | 0.01 | 0.16 | ||||||
| FCF per share | $ | 0.46 | 0.43 | ||||||
| Free cash flow | $m | 164 | 146 | ||||||
| Net debt | $m | 226 | 190 | ||||||
| Book value equity | $m | 616 | 648 | ||||||
| Book value per share | $ | 1.73 | 1.86 | ||||||
| Number of shares | m | 356.97 | 348.06 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 31.77 | 77.88 | ||||||
| P/B LTM | x | 1.57 | 1.49 | ||||||
| P/S LTM | x | 1.21 | 1.23 | ||||||
| P/FCF LTM | x | 5.87 | 6.63 | ||||||
| EV/EBITDA LTM | x | 6.76 | 8.39 | ||||||
| EV/Sales LTM | x | 1.56 | 1.96 | ||||||
| Earnings Yield LTM | % | +3.15% | +1.28% | ||||||
| FCF Yield | % | +17.02% | +15.09% | ||||||
| Quality | |||||||||
| ROE | % | +4.94% | +2.61% | ||||||
| ROIC | % | +4.03% | +2.64% | ||||||
| Operating margin | % | +10.98% | +10.25% | ||||||
| Gross margin | % | +92.77% | +88.05% | ||||||
| FCF/Sales | % | +20.63% | +18.56% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +104.07% | +1.67% | ||||||
| Sales Growth YoY | % | +0.57% | -0.90% | ||||||
| Net Income Growth YoY | % | +85.72% | -0.86% | ||||||
| FCF Growth | % | +44.77% | +28.36% | ||||||
| Operating Profit Growth | % | +32.87% | +22.23% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.30 | 0.27 | ||||||
| Net Debt/EBITDA | x | 1.52 | 1.63 | ||||||
| EBIT/Net interest | x | 2.05 | 1.97 | ||||||
| Net debt/market cap | % | +50.56% | +37.63% | ||||||
| Net debt/Equity | x | 0.37 | 0.29 | ||||||
| Gross debt/equity | x | 0.88 | 0.83 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free